Novyra Pharmachem Limited (BOM:519353)
India flag India · Delayed Price · Currency is INR
8.06
0.00 (0.00%)
At close: Nov 13, 2026

Novyra Pharmachem Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
519337216029
Market Cap Growth
-9.24%154.16%76.35%-65.57%107.71%-12.07%
Enterprise Value
499035205928
Last Close Price
8.0614.975.893.349.704.67

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
----519.54855.13
PS Ratio
0.8488.87--40.0819.30
PB Ratio
8.9714.910.610.350.990.48
P/OCF Ratio
----43.50-

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
0.8086.32--39.6018.79
EV/EBITDA Ratio
----131.88-
EV/EBIT Ratio
----227.84-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.41-0.28-0.04-0.01-0.04-0.01
Net Debt / EBITDA Ratio
0.040.038.750.61-4.924.99
Asset Turnover
1.290.03--0.020.02
Quick Ratio
0.680.221.812.446.553.87
Current Ratio
0.770.861.812.516.664.36
Return on Equity (ROE)
-166.06%-162.40%-1.07%-2.65%0.19%0.06%
Return on Assets (ROA)
-72.08%-87.66%-0.65%-1.61%0.26%-0.36%
Return on Invested Capital (ROIC)
-910.18%-162.40%-1.06%-2.65%0.15%-0.49%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-106.77%-57.92%-1.74%-7.70%0.19%0.12%
Buyback Yield / Dilution
15.00%--2.14%---